Tafinlar 50 mg, Hartkapseln

7680627810010 CH-62781 Kapseln
Tafinlar 50 mg, Hartkapseln
Tafinlar 50 mg, Hartkapseln
Tafinlar 50 mg, Hartkapseln
1 / 3
google

Article details

Package size
28
Selling units
28
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
13/05/2025
Patient information leaflet
Français
13/05/2025
Patient information leaflet
Italien
13/05/2025
Summary of Product Characteristics
Allemand
13/05/2025
Summary of Product Characteristics
Français
13/05/2025
Summary of Product Characteristics
Italien
13/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 908.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/02/2014

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
62781
Drug name
Tafinlar, Hartkapseln
Galenic form
KAHA
ATC Code
L01EC02
Authorization status
Z
Dispensing category
A
First authorization
13/01/2014
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Onkologikum

Package details

Description (FR)
TAFINLAR caps 50 mg bte 28 pce
Description (DE)
TAFINLAR Kaps 50 mg Ds 28 Stk
Market launch
13/01/2014
Narcotic (BTM)
No

Other package sizes (3)

TAFINLAR caps 50 mg bte 120 pce
120 KAP
GTIN: 7680627810027
View
TAFINLAR caps 75 mg bte 28 pce
28 KAP
GTIN: 7680627810034
View
TAFINLAR caps 75 mg bte 120 pce
120 KAP
GTIN: 7680627810041
View